16h
Fintel on MSNEvercore ISI Group Initiates Coverage of West Pharmaceutical Services (WST) with Outperform RecommendationFintel reports that on March 18, 2025, Evercore ISI Group initiated coverage of West Pharmaceutical Services (NYSE:WST) with ...
16h
Fintel on MSNEvercore ISI Group Initiates Coverage of Bio-Techne (TECH) with Outperform RecommendationFintel reports that on March 18, 2025, Evercore ISI Group initiated coverage of Bio-Techne (NasdaqGS:TECH) with a Outperform ...
Evercore ISI analyst Glenn Schorr maintained a Buy rating on Goldman Sachs Group (GS – Research Report) yesterday and set a price target of ...
Evercore ISI analyst Gavin Clark-Gartner maintained a Buy rating on Argenx Se (ARGX – Research Report) yesterday and set a price target of ...
Before GTC, hyperscale cloud customers said that Nvidia had an eight-year lead on the competition and that its "ecosystem is on a different continent," according to Evercore ISI analyst Mark Lipacis.
Evercore ISI sees Apple on track for double-digit earnings growth through 2029, driven by services, AI, and wearables ...
With over 100 legal challenges filed in response to executive actions taken by the Trump Administration, perhaps it was only ...
Nvidia has wrapped its GTC keynote, but investors didn't seem too impressed, with shares ending the day down 3.4%.
Nobody expects the Federal Open Market Committee to cut interest rates on Wednesday. That puts attention squarely on the ...
Investing.com -- Evercore ISI lifted its price target for Apple shares (NASDAQ: AAPL) to $275 from $260 in a note Tuesday, maintaining an Outperform rating on the stock. The firm emphasized the ...
The investment bank said Bio-Techne is a premium growth asset with a strong core business and growth verticals.
Apple (AAPL) was in focus on Tuesday as investment firm Evercore ISI said the tech giant is “well positioned” to have double-digit earnings growth through 2029. Read for more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results